Duckworth questions drug manufacturers on access to RSV treatment
U.S. Sen. Tammy Duckworth, D-Ill., is pushing two major pharmaceutical manufacturers for answers on the lack of access to an immunization that can prevent severe disease from respiratory syncytial virus in babies.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
